Pruritus Market Growth And Restrain Factors Analysis By H2 2017

Overview

Pruritus, or itch, is defined as an unpleasant sensation that provokes the desire to scratch. Pruritus is caused by cancer, cancer treatments, infection, dry skin and reaction to a drug. Symptoms include redness, bumps, spots or blisters, dry, cracked skin and leathery or scaly texture to the skin. Risk factors include heat, allergic, asthma, hay fever, hives and eczema. Treatment includes corticosteroids, antihistamines and antidepressants.

 Click here for sample report @ http://www.wiseguyreports.com/sample-request/1773618-pruritus-pipeline-review-h2-2017

Report Highlights

The Pharmaceutical and Healthcare latest pipeline guide Pruritus - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Pruritus (Dermatology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Pruritus (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Pruritus and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, IND/CTA Filed and Preclinical stages are 4, 12, 6, 1 and 8 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 3 and 1 molecules, respectively.

 Major Scope of the report:

- The pipeline guide provides a snapshot of the global therapeutic landscape of Pruritus (Dermatology). 
- The pipeline guide reviews pipeline therapeutics for Pruritus (Dermatology) by companies and universities/research institutes based on information derived from company and industry-specific sources. 
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. 
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. 
- The pipeline guide reviews key companies involved in Pruritus (Dermatology) therapeutics and enlists all their major and minor projects. 
Table of Contents 

Table of Contents 2 
List of Tables 4 
List of Figures 4 
Introduction 6 
Global Markets Direct Report Coverage 6 
Pruritus - Overview 7 
Pruritus - Therapeutics Development 8 
Pipeline Overview 8 
Pipeline by Companies 9 
Pipeline by Universities/Institutes 12 
Products under Development by Companies 13 
Products under Development by Universities/Institutes 15 
Pruritus - Therapeutics Assessment 16 
Assessment by Target 16 
Assessment by Mechanism of Action 19 
Assessment by Route of Administration 22 
Assessment by Molecule Type 24 
Pruritus - Companies Involved in Therapeutics Development 26 
Albireo Pharma Inc 26 
Allergan Plc 26 
Amorepacific Corp 27  

  .Continued

For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/1773618-pruritus-pipeline-review-h2-2017

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

WISEGUY RESEARCH CONSULTANTS PVT LTD
Office No. 528, Amanora Chambers
Pune - 411028
Maharashtra, India

This release was published on openPR.